These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 10981748

  • 1. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [Abstract] [Full Text] [Related]

  • 2. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T, Nagahiro S, Kitamura K, Nakagawa Y, Hatanaka H, Haritz D, Grochulla F, Haselsberger K, Gabel D.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):120-30. PubMed ID: 11516861
    [Abstract] [Full Text] [Related]

  • 3. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K, Radner H, Pendl G.
    Neurosurgery; 1996 Aug 01; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [Abstract] [Full Text] [Related]

  • 4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 5. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.
    Int J Radiat Oncol Biol Phys; 2000 Apr 01; 47(1):209-18. PubMed ID: 10758326
    [Abstract] [Full Text] [Related]

  • 6. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):663-72. PubMed ID: 9112465
    [Abstract] [Full Text] [Related]

  • 7. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D, Gabel D, Huiskamp R.
    Int J Radiat Oncol Biol Phys; 1994 Mar 30; 28(5):1175-81. PubMed ID: 8175403
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G, Kawabata S, Nonoguchi N, Hiramatsu R, Toho T, Tanaka H, Masunaga SI, Hattori Y, Kirihata M, Ono K, Kuroiwa T, Miyatake SI.
    Radiat Oncol; 2017 Jan 23; 12(1):26. PubMed ID: 28114947
    [Abstract] [Full Text] [Related]

  • 9. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Yang W, Barth RF, Rotaru JH, Boesel CP, Wilkie DA, Bresnahan JC, Hadjiconstantinou M, Goettl VM, Joel DD, Nawrocky MM.
    J Neurooncol; 2000 Jul 23; 48(3):179-90. PubMed ID: 11100816
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
    Gibson CR, Staubus AE, Barth RF, Yang W, Ferketich AK, Moeschberger MM.
    J Neurooncol; 2003 Jul 23; 62(1-2):157-69. PubMed ID: 12749711
    [Abstract] [Full Text] [Related]

  • 11. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T, Nagahiro S, Otersen B, Gabel D, Nakaichi M, Nakagawa Y.
    J Neurooncol; 2002 Sep 23; 59(2):135-42. PubMed ID: 12241106
    [Abstract] [Full Text] [Related]

  • 12. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul 23; 83(1):86-92. PubMed ID: 7782856
    [Abstract] [Full Text] [Related]

  • 13. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V, Begg AC, Huiskamp R, Verrijk R, Bartelink H.
    Radiother Oncol; 1993 Apr 23; 27(1):46-54. PubMed ID: 8327732
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.
    Kraft SL, Gavin PR, Leathers CW, DeHaan CE, Bauer WF, Miller DL, Dorn RV, Griebenow ML.
    Cancer Res; 1994 Mar 01; 54(5):1259-63. PubMed ID: 8118814
    [Abstract] [Full Text] [Related]

  • 15. Prediction of boron concentrations in blood from patients on boron neutron capture therapy.
    Shibata Y, Matsumura A, Yamamoto T, Akutsu H, Yasuda S, Nakai K, Nose T, Yamamoto K, Kumada H, Hori N, Ohtake S.
    Anticancer Res; 2003 Mar 01; 23(6D):5231-5. PubMed ID: 14981995
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T, Nakagawa Y, Kitamura K, Matsumoto K, Hatanaka H.
    J Neurooncol; 1997 May 01; 33(1-2):117-30. PubMed ID: 9151229
    [Abstract] [Full Text] [Related]

  • 17. Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors.
    Horn V, Slánský J, Janku I, Strouf O, Sourek K, Tovarys F.
    Int J Radiat Oncol Biol Phys; 1998 Jun 01; 41(3):631-8. PubMed ID: 9635713
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K, Miyatake S, Kajimoto Y, Kawabata S, Doi A, Yoshida T, Asano T, Kirihata M, Ono K, Kuroiwa T.
    J Neurooncol; 2006 Jul 01; 78(3):227-32. PubMed ID: 16557351
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors.
    Stragliotto G, Fankhauser H.
    Neurosurgery; 1995 Feb 01; 36(2):285-92; discussion 292-3. PubMed ID: 7731508
    [Abstract] [Full Text] [Related]

  • 20. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM, Coderre JA, Hopewell JW, Micca PL, Rezvani M.
    Radiother Oncol; 1994 Aug 01; 32(2):144-53. PubMed ID: 7972908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.